Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Vortioxetine Hydrobromide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

63 API Suppliers, 28 USDMF, 3 JDMF, 13 EU WC, 10 KDMF, 9 NDC API, 41 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

67 Drugs in Development

67 Drugs in Development

INTERMEDIATES

19 Intermediate Suppliers

19 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

119 FDF Dossiers, 18 FDA Orange Book, 66 Europe, 6 Canada, 20 South Africa, 9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE, TABLET;ORAL - EQ 5MG BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 14 SPI Pharma, 2 DKSH, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 1 Clariant, 3 DFE Pharma, 4 Gangwal Chemicals, 1 Ideal Cures, 2 Ingredion Pharma Solutions, 2 Kerry, 2 Keval Exports, 9 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 14 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Silverline Chemicals, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

36 Fillers, Diluents & Binders, 17 Direct Compression, 17 Disintegrants & Superdisintegrants, 14 Chewable & Orodispersible Aids, 12 Taste Masking, 11 Thickeners and Stabilizers, 10 Lubricants & Glidants, 9 Granulation, 9 Co-Processed Excipients, 8 Coating Systems & Additives, 5 Parenteral, 4 Film Formers & Plasticizers, 3 Controlled & Modified Release, 2 Topical, 2 Coloring Agents, 2 Rheology Modifiers, 1 Solubilizers, 1 Surfactant & Foaming Agents, 1 Emulsifying Agents

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 46 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 17 Regulatory FDF Prices, 19 Annual Reports

MARKET PLACE

9 APIs, 4 FDF Dossiers, 1 Intermediates

PATENTS & EXCLUSIVITIES

80 US Patents, 8 US Exclusivities, 12 Health Canada Patents

REF. STANDARDS & IMPURITIES

8 Others

8 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
31/10/2025	Alembic Pharmaceuticals Limited	India	Seongwoo Chemical Co., Ltd.	Su473-29-ND	Vortioxetine hydrobromide	2022-09-16	Alembic Pharmaceuticals Limited (API Unit-lll)	India	API Division Karakhadi, Plot No. 842-843 Tal-Padra, AT.- Karakhadi-391 450, Dist.- Vadodara, Gujarat State, India.
31/10/2025	H. Lundbeck AS	Denmark	Lundbeck Korea Ltd.	Su4496-4-ND	Vortioxetine hydrobromide	2014-07-24	Lundbeck Pharmaceuticals Italy SPA@[Microchem SRL, manufacturer of micronized products]	Italy	Viale dell'Industria, 54 - 35129, Padova (PD), Italy @Fiorenzuola D'Arda (PC) - Via Turati 2, Italy

Vortioxetine Hydrobromide

Vortioxetine Hydrobromide

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

63 API Suppliers

28 USDMF

3 JDMF

13 EU WC

10 KDMF

9 NDC API

41 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

67 Drugs in Development

INTERMEDIATES

19 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

119 FDF Dossiers

18 FDA Orange Book

66 Europe

6 Canada

20 South Africa

9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE

TABLET;ORAL - EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 20MG BASE

TABLET;ORAL - EQ 5MG BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

14 SPI Pharma

2 DKSH

4 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

1 Pfanstiehl

3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 BASF

1 Clariant

3 DFE Pharma

4 Gangwal Chemicals

1 Ideal Cures

2 Ingredion Pharma Solutions

2 Kerry

2 Keval Exports

9 Microlex e.U

2 Nitika Pharmaceutical Specialities

2 Pharmatrans-Sanaq

2 Pluviaendo

3 Prachin Chemical

14 Roquette

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

9 Sigachi Industries

3 Silverline Chemicals

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

36 Fillers, Diluents & Binders

17 Direct Compression

17 Disintegrants & Superdisintegrants

14 Chewable & Orodispersible Aids

12 Taste Masking

11 Thickeners and Stabilizers

10 Lubricants & Glidants

9 Granulation

9 Co-Processed Excipients

8 Coating Systems & Additives

5 Parenteral

4 Film Formers & Plasticizers

3 Controlled & Modified Release

2 Topical

2 Coloring Agents

2 Rheology Modifiers

1 Solubilizers

1 Surfactant & Foaming Agents

1 Emulsifying Agents

DIGITAL CONTENT

2 Data Compilation #PharmaFlow

TABLET;ORAL - EQ 15MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons